Full Year 2022 Futura Medical PLC Earnings Call Transcript
Good morning, everybody. My name is James Barder. I'm the CEO of Futura Medical, and I'm delighted to be joined today by Angela Hildreth, who is the Chief Operating Officer; and Ken James, who is the Executive Director and Head of R&D.
To start with just a little bit of a corporate overview about Futura. We describe ourselves as a virtual organization. We employ 15 staff, including Directors, which enables us to have a low overhead base. We have a significant outsourced infrastructure which includes contract manufacturing and currently use around about 30 consultants that we can switch on and off as and when required.
Our real skill set is applying [sauce] to skin. We develop topical formulations. And we have a clinically proven track record of developing gel formulations. And our key product, which is really what we're going to talk about today, is MED3000, which is a topical gel for erectile dysfunction. It is already approved throughout Europe and in certain countries in the Middle East, and that will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
